hims & hers fda warning letter compounded semaglutide 2025 falls 8% as issues over weight loss drug Last month, the FDA issued

For Canadians running this stack, having both compounds available from a single domestic supplier simplifies the logistics and the quality verification process

Roughly three out of four patients experience some form of nausea during the first four weeks, but most patients say the discomfort is tolerable

One of the most serious concerns is dehydration , which can lead to acute kidney injury (AKI)

Retatrutides Phase 2 results showed ~24% average loss in less than 1 year

Browse the OPS Peptide Science catalog for verified research-grade retatrutide

A few folks experience gallstones or mild stomach upset after beginning this drug